Literature DB >> 10458925

Elevated oxygen tension inhibits flow-induced dilation of skeletal muscle arterioles.

J C Frisbee1, J H Lombard.   

Abstract

The purpose of this study was to determine if elevated oxygen tension affects flow-induced dilation of in situ skeletal muscle arterioles. Cremaster muscle preparations from Sprague-Dawley rats were superfused with physiological salt solution (PSS) and viewed via television microscopy. A video micrometer was used to measure changes in arteriolar diameter in response to the increase in flow produced by occlusion of a parallel branch from the parent arteriole. Erythrocyte velocity was measured with an optical Doppler velocimeter. The superfusate PO(2) was altered by changing the oxygen concentration of the equilibration gas between 0 and 21% O(2). Elevation of superfusate PO(2) to 10% O(2) and 21% O(2) significantly decreased arteriolar diameter compared to the control diameter during 0% O(2) superfusion. Increases in arteriolar diameter during parallel arteriolar occlusion were reduced as superfusate PO(2) was elevated. However, elevated PO(2) had no significant effect on erythrocyte velocity through the perfused daughter vessel, either prior to or during parallel occlusion. As a result, blood flow through the dilating vessel was reduced with elevated PO(2). As a result of the reduced arteriolar diameter, wall shear rate in the perfused daughter vessel was increased with elevated PO(2), both prior to and during parallel occlusion. These observations demonstrate that elevated PO(2) can override flow-induced vasodilation in the skeletal muscle microcirculation, leading to the persistence of an elevated wall shear rate. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458925     DOI: 10.1006/mvre.1999.2169

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  7 in total

1.  Arterioles' contribution to oxygen supply to the skeletal muscles at rest.

Authors:  Masahiro Shibata; Shigeru Ichioka; Tatsuo Togawa; Akira Kamiya
Journal:  Eur J Appl Physiol       Date:  2006-04-25       Impact factor: 3.078

2.  Oxygen sensing and conducted vasomotor responses in mouse cremaster arterioles in situ.

Authors:  Anh Thuc Ngo; Lars Jørn Jensen; Mads Riemann; Niels-Henrik Holstein-Rathlou; Christian Torp-Pedersen
Journal:  Pflugers Arch       Date:  2010-04-11       Impact factor: 3.657

3.  Potassium inhibits nitric oxide and adenosine arteriolar vasodilatation via K(IR) and Na(+)/K(+) ATPase: implications for redundancy in active hyperaemia.

Authors:  Iain R Lamb; Coral L Murrant
Journal:  J Physiol       Date:  2015-11-15       Impact factor: 5.182

4.  Moderate hyperoxic versus near-physiological oxygen targets during and after coronary artery bypass surgery: a randomised controlled trial.

Authors:  Bob Smit; Yvo M Smulders; Monique C de Waard; Christa Boer; Alexander B A Vonk; Dennis Veerhoek; Suzanne Kamminga; Harm-Jan S de Grooth; Juan J García-Vallejo; Rene J P Musters; Armand R J Girbes; Heleen M Oudemans-van Straaten; Angelique M E Spoelstra-de Man
Journal:  Crit Care       Date:  2016-03-10       Impact factor: 9.097

5.  Hyperoxia does not directly affect vascular tone in isolated arteries from mice.

Authors:  B Smit; Y M Smulders; M C de Waard; H M Oudemans-van Straaten; A R J Girbes; E C Eringa; A M E Spoelstra-de Man
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

6.  Significance of K(ATP) channels, L-type Ca²⁺ channels and CYP450-4A enzymes in oxygen sensing in mouse cremaster muscle arterioles in vivo.

Authors:  Anh Thuc Ngo; Mads Riemann; Niels-Henrik Holstein-Rathlou; Christian Torp-Pedersen; Lars Jørn Jensen
Journal:  BMC Physiol       Date:  2013-05-12

7.  Effects of hyperoxia on vascular tone in animal models: systematic review and meta-analysis.

Authors:  Bob Smit; Yvo M Smulders; Etto C Eringa; Heleen M Oudemans-van Straaten; Armand R J Girbes; Kimberley E Wever; Carlijn R Hooijmans; Angelique M E Spoelstra-de Man
Journal:  Crit Care       Date:  2018-08-04       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.